Protein Electrophoresis & Western Analysis Life Science Dashboard Series 3 (NA & EU) - Analysis, Technologies & Forecasts - Key Vendors: Abnova, Agilent Technologies, Biomatik - Research and Markets
Thermo Fisher Scientific to Buy FEI for $4.2 Billion -- Update
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Continued technology advancements and market expansion support Illumina's narrow moat.
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
Get our sector-by-sector take on the bond market, plus our five best bond ideas.
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
Widening investment-grade credit spreads and rising interest rates lead to losses.